Global GLP-1 Agonist Injection Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.
The global GLP-1 Agonist Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Agonist Injection Industry Forecast” looks at past sales and reviews total world GLP-1 Agonist Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected GLP-1 Agonist Injection sales for 2024 through 2030. With GLP-1 Agonist Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Agonist Injection industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Agonist Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Agonist Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Agonist Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Agonist Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Agonist Injection.
United States market for GLP-1 Agonist Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for GLP-1 Agonist Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for GLP-1 Agonist Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key GLP-1 Agonist Injection players cover Novo Nordisk, Eli Lilly, AstraZeneca, GSK, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Agonist Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global GLP-1 Agonist Injection market?
What factors are driving GLP-1 Agonist Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Agonist Injection market opportunities vary by end market size?
How does GLP-1 Agonist Injection break out by Type, by Application?
GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.
The global GLP-1 Agonist Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Agonist Injection Industry Forecast” looks at past sales and reviews total world GLP-1 Agonist Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected GLP-1 Agonist Injection sales for 2024 through 2030. With GLP-1 Agonist Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Agonist Injection industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Agonist Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Agonist Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Agonist Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Agonist Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Agonist Injection.
United States market for GLP-1 Agonist Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for GLP-1 Agonist Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for GLP-1 Agonist Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key GLP-1 Agonist Injection players cover Novo Nordisk, Eli Lilly, AstraZeneca, GSK, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Agonist Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Short-acting Preparations
- Long-acting Preparations
- Diabetes
- Obesity
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- Eli Lilly
- AstraZeneca
- GSK
- Sanofi
- Amylin
- Huadong Medicine
- Shanghai Benemae Pharmaceutical Corporation
What is the 10-year outlook for the global GLP-1 Agonist Injection market?
What factors are driving GLP-1 Agonist Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Agonist Injection market opportunities vary by end market size?
How does GLP-1 Agonist Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Agonist Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for GLP-1 Agonist Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for GLP-1 Agonist Injection by Country/Region, 2019, 2023 & 2030
2.2 GLP-1 Agonist Injection Segment by Type
2.2.1 Short-acting Preparations
2.2.2 Long-acting Preparations
2.3 GLP-1 Agonist Injection Sales by Type
2.3.1 Global GLP-1 Agonist Injection Sales Market Share by Type (2019-2024)
2.3.2 Global GLP-1 Agonist Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global GLP-1 Agonist Injection Sale Price by Type (2019-2024)
2.4 GLP-1 Agonist Injection Segment by Application
2.4.1 Diabetes
2.4.2 Obesity
2.5 GLP-1 Agonist Injection Sales by Application
2.5.1 Global GLP-1 Agonist Injection Sale Market Share by Application (2019-2024)
2.5.2 Global GLP-1 Agonist Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global GLP-1 Agonist Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global GLP-1 Agonist Injection Breakdown Data by Company
3.1.1 Global GLP-1 Agonist Injection Annual Sales by Company (2019-2024)
3.1.2 Global GLP-1 Agonist Injection Sales Market Share by Company (2019-2024)
3.2 Global GLP-1 Agonist Injection Annual Revenue by Company (2019-2024)
3.2.1 Global GLP-1 Agonist Injection Revenue by Company (2019-2024)
3.2.2 Global GLP-1 Agonist Injection Revenue Market Share by Company (2019-2024)
3.3 Global GLP-1 Agonist Injection Sale Price by Company
3.4 Key Manufacturers GLP-1 Agonist Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Agonist Injection Product Location Distribution
3.4.2 Players GLP-1 Agonist Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1 AGONIST INJECTION BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Agonist Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global GLP-1 Agonist Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global GLP-1 Agonist Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic GLP-1 Agonist Injection Market Size by Country/Region (2019-2024)
4.2.1 Global GLP-1 Agonist Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global GLP-1 Agonist Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas GLP-1 Agonist Injection Sales Growth
4.4 APAC GLP-1 Agonist Injection Sales Growth
4.5 Europe GLP-1 Agonist Injection Sales Growth
4.6 Middle East & Africa GLP-1 Agonist Injection Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Agonist Injection Sales by Country
5.1.1 Americas GLP-1 Agonist Injection Sales by Country (2019-2024)
5.1.2 Americas GLP-1 Agonist Injection Revenue by Country (2019-2024)
5.2 Americas GLP-1 Agonist Injection Sales by Type (2019-2024)
5.3 Americas GLP-1 Agonist Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Agonist Injection Sales by Region
6.1.1 APAC GLP-1 Agonist Injection Sales by Region (2019-2024)
6.1.2 APAC GLP-1 Agonist Injection Revenue by Region (2019-2024)
6.2 APAC GLP-1 Agonist Injection Sales by Type (2019-2024)
6.3 APAC GLP-1 Agonist Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Agonist Injection by Country
7.1.1 Europe GLP-1 Agonist Injection Sales by Country (2019-2024)
7.1.2 Europe GLP-1 Agonist Injection Revenue by Country (2019-2024)
7.2 Europe GLP-1 Agonist Injection Sales by Type (2019-2024)
7.3 Europe GLP-1 Agonist Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Agonist Injection by Country
8.1.1 Middle East & Africa GLP-1 Agonist Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa GLP-1 Agonist Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa GLP-1 Agonist Injection Sales by Type (2019-2024)
8.3 Middle East & Africa GLP-1 Agonist Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Agonist Injection
10.3 Manufacturing Process Analysis of GLP-1 Agonist Injection
10.4 Industry Chain Structure of GLP-1 Agonist Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Agonist Injection Distributors
11.3 GLP-1 Agonist Injection Customer
12 WORLD FORECAST REVIEW FOR GLP-1 AGONIST INJECTION BY GEOGRAPHIC REGION
12.1 Global GLP-1 Agonist Injection Market Size Forecast by Region
12.1.1 Global GLP-1 Agonist Injection Forecast by Region (2025-2030)
12.1.2 Global GLP-1 Agonist Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global GLP-1 Agonist Injection Forecast by Type (2025-2030)
12.7 Global GLP-1 Agonist Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 Agonist Injection Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly GLP-1 Agonist Injection Product Portfolios and Specifications
13.2.3 Eli Lilly GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca GLP-1 Agonist Injection Product Portfolios and Specifications
13.3.3 AstraZeneca GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK GLP-1 Agonist Injection Product Portfolios and Specifications
13.4.3 GSK GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi GLP-1 Agonist Injection Product Portfolios and Specifications
13.5.3 Sanofi GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Amylin
13.6.1 Amylin Company Information
13.6.2 Amylin GLP-1 Agonist Injection Product Portfolios and Specifications
13.6.3 Amylin GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Amylin Main Business Overview
13.6.5 Amylin Latest Developments
13.7 Huadong Medicine
13.7.1 Huadong Medicine Company Information
13.7.2 Huadong Medicine GLP-1 Agonist Injection Product Portfolios and Specifications
13.7.3 Huadong Medicine GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Huadong Medicine Main Business Overview
13.7.5 Huadong Medicine Latest Developments
13.8 Shanghai Benemae Pharmaceutical Corporation
13.8.1 Shanghai Benemae Pharmaceutical Corporation Company Information
13.8.2 Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Product Portfolios and Specifications
13.8.3 Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Shanghai Benemae Pharmaceutical Corporation Main Business Overview
13.8.5 Shanghai Benemae Pharmaceutical Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Agonist Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for GLP-1 Agonist Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for GLP-1 Agonist Injection by Country/Region, 2019, 2023 & 2030
2.2 GLP-1 Agonist Injection Segment by Type
2.2.1 Short-acting Preparations
2.2.2 Long-acting Preparations
2.3 GLP-1 Agonist Injection Sales by Type
2.3.1 Global GLP-1 Agonist Injection Sales Market Share by Type (2019-2024)
2.3.2 Global GLP-1 Agonist Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global GLP-1 Agonist Injection Sale Price by Type (2019-2024)
2.4 GLP-1 Agonist Injection Segment by Application
2.4.1 Diabetes
2.4.2 Obesity
2.5 GLP-1 Agonist Injection Sales by Application
2.5.1 Global GLP-1 Agonist Injection Sale Market Share by Application (2019-2024)
2.5.2 Global GLP-1 Agonist Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global GLP-1 Agonist Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global GLP-1 Agonist Injection Breakdown Data by Company
3.1.1 Global GLP-1 Agonist Injection Annual Sales by Company (2019-2024)
3.1.2 Global GLP-1 Agonist Injection Sales Market Share by Company (2019-2024)
3.2 Global GLP-1 Agonist Injection Annual Revenue by Company (2019-2024)
3.2.1 Global GLP-1 Agonist Injection Revenue by Company (2019-2024)
3.2.2 Global GLP-1 Agonist Injection Revenue Market Share by Company (2019-2024)
3.3 Global GLP-1 Agonist Injection Sale Price by Company
3.4 Key Manufacturers GLP-1 Agonist Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Agonist Injection Product Location Distribution
3.4.2 Players GLP-1 Agonist Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1 AGONIST INJECTION BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Agonist Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global GLP-1 Agonist Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global GLP-1 Agonist Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic GLP-1 Agonist Injection Market Size by Country/Region (2019-2024)
4.2.1 Global GLP-1 Agonist Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global GLP-1 Agonist Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas GLP-1 Agonist Injection Sales Growth
4.4 APAC GLP-1 Agonist Injection Sales Growth
4.5 Europe GLP-1 Agonist Injection Sales Growth
4.6 Middle East & Africa GLP-1 Agonist Injection Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Agonist Injection Sales by Country
5.1.1 Americas GLP-1 Agonist Injection Sales by Country (2019-2024)
5.1.2 Americas GLP-1 Agonist Injection Revenue by Country (2019-2024)
5.2 Americas GLP-1 Agonist Injection Sales by Type (2019-2024)
5.3 Americas GLP-1 Agonist Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Agonist Injection Sales by Region
6.1.1 APAC GLP-1 Agonist Injection Sales by Region (2019-2024)
6.1.2 APAC GLP-1 Agonist Injection Revenue by Region (2019-2024)
6.2 APAC GLP-1 Agonist Injection Sales by Type (2019-2024)
6.3 APAC GLP-1 Agonist Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Agonist Injection by Country
7.1.1 Europe GLP-1 Agonist Injection Sales by Country (2019-2024)
7.1.2 Europe GLP-1 Agonist Injection Revenue by Country (2019-2024)
7.2 Europe GLP-1 Agonist Injection Sales by Type (2019-2024)
7.3 Europe GLP-1 Agonist Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Agonist Injection by Country
8.1.1 Middle East & Africa GLP-1 Agonist Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa GLP-1 Agonist Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa GLP-1 Agonist Injection Sales by Type (2019-2024)
8.3 Middle East & Africa GLP-1 Agonist Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Agonist Injection
10.3 Manufacturing Process Analysis of GLP-1 Agonist Injection
10.4 Industry Chain Structure of GLP-1 Agonist Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Agonist Injection Distributors
11.3 GLP-1 Agonist Injection Customer
12 WORLD FORECAST REVIEW FOR GLP-1 AGONIST INJECTION BY GEOGRAPHIC REGION
12.1 Global GLP-1 Agonist Injection Market Size Forecast by Region
12.1.1 Global GLP-1 Agonist Injection Forecast by Region (2025-2030)
12.1.2 Global GLP-1 Agonist Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global GLP-1 Agonist Injection Forecast by Type (2025-2030)
12.7 Global GLP-1 Agonist Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 Agonist Injection Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly GLP-1 Agonist Injection Product Portfolios and Specifications
13.2.3 Eli Lilly GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca GLP-1 Agonist Injection Product Portfolios and Specifications
13.3.3 AstraZeneca GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK GLP-1 Agonist Injection Product Portfolios and Specifications
13.4.3 GSK GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi GLP-1 Agonist Injection Product Portfolios and Specifications
13.5.3 Sanofi GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Amylin
13.6.1 Amylin Company Information
13.6.2 Amylin GLP-1 Agonist Injection Product Portfolios and Specifications
13.6.3 Amylin GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Amylin Main Business Overview
13.6.5 Amylin Latest Developments
13.7 Huadong Medicine
13.7.1 Huadong Medicine Company Information
13.7.2 Huadong Medicine GLP-1 Agonist Injection Product Portfolios and Specifications
13.7.3 Huadong Medicine GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Huadong Medicine Main Business Overview
13.7.5 Huadong Medicine Latest Developments
13.8 Shanghai Benemae Pharmaceutical Corporation
13.8.1 Shanghai Benemae Pharmaceutical Corporation Company Information
13.8.2 Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Product Portfolios and Specifications
13.8.3 Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Shanghai Benemae Pharmaceutical Corporation Main Business Overview
13.8.5 Shanghai Benemae Pharmaceutical Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GLP-1 Agonist Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. GLP-1 Agonist Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Short-acting Preparations
Table 4. Major Players of Long-acting Preparations
Table 5. Global GLP-1 Agonist Injection Sales by Type (2019-2024) & (K Dose)
Table 6. Global GLP-1 Agonist Injection Sales Market Share by Type (2019-2024)
Table 7. Global GLP-1 Agonist Injection Revenue by Type (2019-2024) & ($ million)
Table 8. Global GLP-1 Agonist Injection Revenue Market Share by Type (2019-2024)
Table 9. Global GLP-1 Agonist Injection Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global GLP-1 Agonist Injection Sale by Application (2019-2024) & (K Dose)
Table 11. Global GLP-1 Agonist Injection Sale Market Share by Application (2019-2024)
Table 12. Global GLP-1 Agonist Injection Revenue by Application (2019-2024) & ($ million)
Table 13. Global GLP-1 Agonist Injection Revenue Market Share by Application (2019-2024)
Table 14. Global GLP-1 Agonist Injection Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global GLP-1 Agonist Injection Sales by Company (2019-2024) & (K Dose)
Table 16. Global GLP-1 Agonist Injection Sales Market Share by Company (2019-2024)
Table 17. Global GLP-1 Agonist Injection Revenue by Company (2019-2024) & ($ millions)
Table 18. Global GLP-1 Agonist Injection Revenue Market Share by Company (2019-2024)
Table 19. Global GLP-1 Agonist Injection Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers GLP-1 Agonist Injection Producing Area Distribution and Sales Area
Table 21. Players GLP-1 Agonist Injection Products Offered
Table 22. GLP-1 Agonist Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GLP-1 Agonist Injection Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global GLP-1 Agonist Injection Sales Market Share Geographic Region (2019-2024)
Table 27. Global GLP-1 Agonist Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global GLP-1 Agonist Injection Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global GLP-1 Agonist Injection Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global GLP-1 Agonist Injection Sales Market Share by Country/Region (2019-2024)
Table 31. Global GLP-1 Agonist Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global GLP-1 Agonist Injection Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas GLP-1 Agonist Injection Sales by Country (2019-2024) & (K Dose)
Table 34. Americas GLP-1 Agonist Injection Sales Market Share by Country (2019-2024)
Table 35. Americas GLP-1 Agonist Injection Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas GLP-1 Agonist Injection Sales by Type (2019-2024) & (K Dose)
Table 37. Americas GLP-1 Agonist Injection Sales by Application (2019-2024) & (K Dose)
Table 38. APAC GLP-1 Agonist Injection Sales by Region (2019-2024) & (K Dose)
Table 39. APAC GLP-1 Agonist Injection Sales Market Share by Region (2019-2024)
Table 40. APAC GLP-1 Agonist Injection Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC GLP-1 Agonist Injection Sales by Type (2019-2024) & (K Dose)
Table 42. APAC GLP-1 Agonist Injection Sales by Application (2019-2024) & (K Dose)
Table 43. Europe GLP-1 Agonist Injection Sales by Country (2019-2024) & (K Dose)
Table 44. Europe GLP-1 Agonist Injection Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe GLP-1 Agonist Injection Sales by Type (2019-2024) & (K Dose)
Table 46. Europe GLP-1 Agonist Injection Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa GLP-1 Agonist Injection Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa GLP-1 Agonist Injection Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa GLP-1 Agonist Injection Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa GLP-1 Agonist Injection Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of GLP-1 Agonist Injection
Table 52. Key Market Challenges & Risks of GLP-1 Agonist Injection
Table 53. Key Industry Trends of GLP-1 Agonist Injection
Table 54. GLP-1 Agonist Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GLP-1 Agonist Injection Distributors List
Table 57. GLP-1 Agonist Injection Customer List
Table 58. Global GLP-1 Agonist Injection Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global GLP-1 Agonist Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas GLP-1 Agonist Injection Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas GLP-1 Agonist Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC GLP-1 Agonist Injection Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC GLP-1 Agonist Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe GLP-1 Agonist Injection Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe GLP-1 Agonist Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa GLP-1 Agonist Injection Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa GLP-1 Agonist Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global GLP-1 Agonist Injection Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global GLP-1 Agonist Injection Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global GLP-1 Agonist Injection Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global GLP-1 Agonist Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Novo Nordisk Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk GLP-1 Agonist Injection Product Portfolios and Specifications
Table 74. Novo Nordisk GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. Eli Lilly Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Eli Lilly GLP-1 Agonist Injection Product Portfolios and Specifications
Table 79. Eli Lilly GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. Eli Lilly Main Business
Table 81. Eli Lilly Latest Developments
Table 82. AstraZeneca Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. AstraZeneca GLP-1 Agonist Injection Product Portfolios and Specifications
Table 84. AstraZeneca GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. AstraZeneca Main Business
Table 86. AstraZeneca Latest Developments
Table 87. GSK Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK GLP-1 Agonist Injection Product Portfolios and Specifications
Table 89. GSK GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Sanofi Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi GLP-1 Agonist Injection Product Portfolios and Specifications
Table 94. Sanofi GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. Amylin Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Amylin GLP-1 Agonist Injection Product Portfolios and Specifications
Table 99. Amylin GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. Amylin Main Business
Table 101. Amylin Latest Developments
Table 102. Huadong Medicine Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Huadong Medicine GLP-1 Agonist Injection Product Portfolios and Specifications
Table 104. Huadong Medicine GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. Huadong Medicine Main Business
Table 106. Huadong Medicine Latest Developments
Table 107. Shanghai Benemae Pharmaceutical Corporation Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Product Portfolios and Specifications
Table 109. Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 110. Shanghai Benemae Pharmaceutical Corporation Main Business
Table 111. Shanghai Benemae Pharmaceutical Corporation Latest Developments
Table 1. GLP-1 Agonist Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. GLP-1 Agonist Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Short-acting Preparations
Table 4. Major Players of Long-acting Preparations
Table 5. Global GLP-1 Agonist Injection Sales by Type (2019-2024) & (K Dose)
Table 6. Global GLP-1 Agonist Injection Sales Market Share by Type (2019-2024)
Table 7. Global GLP-1 Agonist Injection Revenue by Type (2019-2024) & ($ million)
Table 8. Global GLP-1 Agonist Injection Revenue Market Share by Type (2019-2024)
Table 9. Global GLP-1 Agonist Injection Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global GLP-1 Agonist Injection Sale by Application (2019-2024) & (K Dose)
Table 11. Global GLP-1 Agonist Injection Sale Market Share by Application (2019-2024)
Table 12. Global GLP-1 Agonist Injection Revenue by Application (2019-2024) & ($ million)
Table 13. Global GLP-1 Agonist Injection Revenue Market Share by Application (2019-2024)
Table 14. Global GLP-1 Agonist Injection Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global GLP-1 Agonist Injection Sales by Company (2019-2024) & (K Dose)
Table 16. Global GLP-1 Agonist Injection Sales Market Share by Company (2019-2024)
Table 17. Global GLP-1 Agonist Injection Revenue by Company (2019-2024) & ($ millions)
Table 18. Global GLP-1 Agonist Injection Revenue Market Share by Company (2019-2024)
Table 19. Global GLP-1 Agonist Injection Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers GLP-1 Agonist Injection Producing Area Distribution and Sales Area
Table 21. Players GLP-1 Agonist Injection Products Offered
Table 22. GLP-1 Agonist Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GLP-1 Agonist Injection Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global GLP-1 Agonist Injection Sales Market Share Geographic Region (2019-2024)
Table 27. Global GLP-1 Agonist Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global GLP-1 Agonist Injection Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global GLP-1 Agonist Injection Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global GLP-1 Agonist Injection Sales Market Share by Country/Region (2019-2024)
Table 31. Global GLP-1 Agonist Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global GLP-1 Agonist Injection Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas GLP-1 Agonist Injection Sales by Country (2019-2024) & (K Dose)
Table 34. Americas GLP-1 Agonist Injection Sales Market Share by Country (2019-2024)
Table 35. Americas GLP-1 Agonist Injection Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas GLP-1 Agonist Injection Sales by Type (2019-2024) & (K Dose)
Table 37. Americas GLP-1 Agonist Injection Sales by Application (2019-2024) & (K Dose)
Table 38. APAC GLP-1 Agonist Injection Sales by Region (2019-2024) & (K Dose)
Table 39. APAC GLP-1 Agonist Injection Sales Market Share by Region (2019-2024)
Table 40. APAC GLP-1 Agonist Injection Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC GLP-1 Agonist Injection Sales by Type (2019-2024) & (K Dose)
Table 42. APAC GLP-1 Agonist Injection Sales by Application (2019-2024) & (K Dose)
Table 43. Europe GLP-1 Agonist Injection Sales by Country (2019-2024) & (K Dose)
Table 44. Europe GLP-1 Agonist Injection Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe GLP-1 Agonist Injection Sales by Type (2019-2024) & (K Dose)
Table 46. Europe GLP-1 Agonist Injection Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa GLP-1 Agonist Injection Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa GLP-1 Agonist Injection Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa GLP-1 Agonist Injection Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa GLP-1 Agonist Injection Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of GLP-1 Agonist Injection
Table 52. Key Market Challenges & Risks of GLP-1 Agonist Injection
Table 53. Key Industry Trends of GLP-1 Agonist Injection
Table 54. GLP-1 Agonist Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GLP-1 Agonist Injection Distributors List
Table 57. GLP-1 Agonist Injection Customer List
Table 58. Global GLP-1 Agonist Injection Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global GLP-1 Agonist Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas GLP-1 Agonist Injection Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas GLP-1 Agonist Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC GLP-1 Agonist Injection Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC GLP-1 Agonist Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe GLP-1 Agonist Injection Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe GLP-1 Agonist Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa GLP-1 Agonist Injection Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa GLP-1 Agonist Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global GLP-1 Agonist Injection Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global GLP-1 Agonist Injection Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global GLP-1 Agonist Injection Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global GLP-1 Agonist Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Novo Nordisk Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk GLP-1 Agonist Injection Product Portfolios and Specifications
Table 74. Novo Nordisk GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. Eli Lilly Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Eli Lilly GLP-1 Agonist Injection Product Portfolios and Specifications
Table 79. Eli Lilly GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. Eli Lilly Main Business
Table 81. Eli Lilly Latest Developments
Table 82. AstraZeneca Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. AstraZeneca GLP-1 Agonist Injection Product Portfolios and Specifications
Table 84. AstraZeneca GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. AstraZeneca Main Business
Table 86. AstraZeneca Latest Developments
Table 87. GSK Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK GLP-1 Agonist Injection Product Portfolios and Specifications
Table 89. GSK GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Sanofi Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi GLP-1 Agonist Injection Product Portfolios and Specifications
Table 94. Sanofi GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. Amylin Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Amylin GLP-1 Agonist Injection Product Portfolios and Specifications
Table 99. Amylin GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. Amylin Main Business
Table 101. Amylin Latest Developments
Table 102. Huadong Medicine Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Huadong Medicine GLP-1 Agonist Injection Product Portfolios and Specifications
Table 104. Huadong Medicine GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. Huadong Medicine Main Business
Table 106. Huadong Medicine Latest Developments
Table 107. Shanghai Benemae Pharmaceutical Corporation Basic Information, GLP-1 Agonist Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Product Portfolios and Specifications
Table 109. Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 110. Shanghai Benemae Pharmaceutical Corporation Main Business
Table 111. Shanghai Benemae Pharmaceutical Corporation Latest Developments
LIST OF FIGURES
Figure 1. Picture of GLP-1 Agonist Injection
Figure 2. GLP-1 Agonist Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Agonist Injection Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global GLP-1 Agonist Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. GLP-1 Agonist Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. GLP-1 Agonist Injection Sales Market Share by Country/Region (2023)
Figure 10. GLP-1 Agonist Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Short-acting Preparations
Figure 12. Product Picture of Long-acting Preparations
Figure 13. Global GLP-1 Agonist Injection Sales Market Share by Type in 2023
Figure 14. Global GLP-1 Agonist Injection Revenue Market Share by Type (2019-2024)
Figure 15. GLP-1 Agonist Injection Consumed in Diabetes
Figure 16. Global GLP-1 Agonist Injection Market: Diabetes (2019-2024) & (K Dose)
Figure 17. GLP-1 Agonist Injection Consumed in Obesity
Figure 18. Global GLP-1 Agonist Injection Market: Obesity (2019-2024) & (K Dose)
Figure 19. Global GLP-1 Agonist Injection Sale Market Share by Application (2023)
Figure 20. Global GLP-1 Agonist Injection Revenue Market Share by Application in 2023
Figure 21. GLP-1 Agonist Injection Sales by Company in 2023 (K Dose)
Figure 22. Global GLP-1 Agonist Injection Sales Market Share by Company in 2023
Figure 23. GLP-1 Agonist Injection Revenue by Company in 2023 ($ millions)
Figure 24. Global GLP-1 Agonist Injection Revenue Market Share by Company in 2023
Figure 25. Global GLP-1 Agonist Injection Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global GLP-1 Agonist Injection Revenue Market Share by Geographic Region in 2023
Figure 27. Americas GLP-1 Agonist Injection Sales 2019-2024 (K Dose)
Figure 28. Americas GLP-1 Agonist Injection Revenue 2019-2024 ($ millions)
Figure 29. APAC GLP-1 Agonist Injection Sales 2019-2024 (K Dose)
Figure 30. APAC GLP-1 Agonist Injection Revenue 2019-2024 ($ millions)
Figure 31. Europe GLP-1 Agonist Injection Sales 2019-2024 (K Dose)
Figure 32. Europe GLP-1 Agonist Injection Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa GLP-1 Agonist Injection Sales 2019-2024 (K Dose)
Figure 34. Middle East & Africa GLP-1 Agonist Injection Revenue 2019-2024 ($ millions)
Figure 35. Americas GLP-1 Agonist Injection Sales Market Share by Country in 2023
Figure 36. Americas GLP-1 Agonist Injection Revenue Market Share by Country (2019-2024)
Figure 37. Americas GLP-1 Agonist Injection Sales Market Share by Type (2019-2024)
Figure 38. Americas GLP-1 Agonist Injection Sales Market Share by Application (2019-2024)
Figure 39. United States GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC GLP-1 Agonist Injection Sales Market Share by Region in 2023
Figure 44. APAC GLP-1 Agonist Injection Revenue Market Share by Region (2019-2024)
Figure 45. APAC GLP-1 Agonist Injection Sales Market Share by Type (2019-2024)
Figure 46. APAC GLP-1 Agonist Injection Sales Market Share by Application (2019-2024)
Figure 47. China GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 51. India GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe GLP-1 Agonist Injection Sales Market Share by Country in 2023
Figure 55. Europe GLP-1 Agonist Injection Revenue Market Share by Country (2019-2024)
Figure 56. Europe GLP-1 Agonist Injection Sales Market Share by Type (2019-2024)
Figure 57. Europe GLP-1 Agonist Injection Sales Market Share by Application (2019-2024)
Figure 58. Germany GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 59. France GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 60. UK GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa GLP-1 Agonist Injection Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa GLP-1 Agonist Injection Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa GLP-1 Agonist Injection Sales Market Share by Application (2019-2024)
Figure 66. Egypt GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of GLP-1 Agonist Injection in 2023
Figure 72. Manufacturing Process Analysis of GLP-1 Agonist Injection
Figure 73. Industry Chain Structure of GLP-1 Agonist Injection
Figure 74. Channels of Distribution
Figure 75. Global GLP-1 Agonist Injection Sales Market Forecast by Region (2025-2030)
Figure 76. Global GLP-1 Agonist Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global GLP-1 Agonist Injection Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global GLP-1 Agonist Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global GLP-1 Agonist Injection Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global GLP-1 Agonist Injection Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of GLP-1 Agonist Injection
Figure 2. GLP-1 Agonist Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Agonist Injection Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global GLP-1 Agonist Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. GLP-1 Agonist Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. GLP-1 Agonist Injection Sales Market Share by Country/Region (2023)
Figure 10. GLP-1 Agonist Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Short-acting Preparations
Figure 12. Product Picture of Long-acting Preparations
Figure 13. Global GLP-1 Agonist Injection Sales Market Share by Type in 2023
Figure 14. Global GLP-1 Agonist Injection Revenue Market Share by Type (2019-2024)
Figure 15. GLP-1 Agonist Injection Consumed in Diabetes
Figure 16. Global GLP-1 Agonist Injection Market: Diabetes (2019-2024) & (K Dose)
Figure 17. GLP-1 Agonist Injection Consumed in Obesity
Figure 18. Global GLP-1 Agonist Injection Market: Obesity (2019-2024) & (K Dose)
Figure 19. Global GLP-1 Agonist Injection Sale Market Share by Application (2023)
Figure 20. Global GLP-1 Agonist Injection Revenue Market Share by Application in 2023
Figure 21. GLP-1 Agonist Injection Sales by Company in 2023 (K Dose)
Figure 22. Global GLP-1 Agonist Injection Sales Market Share by Company in 2023
Figure 23. GLP-1 Agonist Injection Revenue by Company in 2023 ($ millions)
Figure 24. Global GLP-1 Agonist Injection Revenue Market Share by Company in 2023
Figure 25. Global GLP-1 Agonist Injection Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global GLP-1 Agonist Injection Revenue Market Share by Geographic Region in 2023
Figure 27. Americas GLP-1 Agonist Injection Sales 2019-2024 (K Dose)
Figure 28. Americas GLP-1 Agonist Injection Revenue 2019-2024 ($ millions)
Figure 29. APAC GLP-1 Agonist Injection Sales 2019-2024 (K Dose)
Figure 30. APAC GLP-1 Agonist Injection Revenue 2019-2024 ($ millions)
Figure 31. Europe GLP-1 Agonist Injection Sales 2019-2024 (K Dose)
Figure 32. Europe GLP-1 Agonist Injection Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa GLP-1 Agonist Injection Sales 2019-2024 (K Dose)
Figure 34. Middle East & Africa GLP-1 Agonist Injection Revenue 2019-2024 ($ millions)
Figure 35. Americas GLP-1 Agonist Injection Sales Market Share by Country in 2023
Figure 36. Americas GLP-1 Agonist Injection Revenue Market Share by Country (2019-2024)
Figure 37. Americas GLP-1 Agonist Injection Sales Market Share by Type (2019-2024)
Figure 38. Americas GLP-1 Agonist Injection Sales Market Share by Application (2019-2024)
Figure 39. United States GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC GLP-1 Agonist Injection Sales Market Share by Region in 2023
Figure 44. APAC GLP-1 Agonist Injection Revenue Market Share by Region (2019-2024)
Figure 45. APAC GLP-1 Agonist Injection Sales Market Share by Type (2019-2024)
Figure 46. APAC GLP-1 Agonist Injection Sales Market Share by Application (2019-2024)
Figure 47. China GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 51. India GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe GLP-1 Agonist Injection Sales Market Share by Country in 2023
Figure 55. Europe GLP-1 Agonist Injection Revenue Market Share by Country (2019-2024)
Figure 56. Europe GLP-1 Agonist Injection Sales Market Share by Type (2019-2024)
Figure 57. Europe GLP-1 Agonist Injection Sales Market Share by Application (2019-2024)
Figure 58. Germany GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 59. France GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 60. UK GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa GLP-1 Agonist Injection Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa GLP-1 Agonist Injection Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa GLP-1 Agonist Injection Sales Market Share by Application (2019-2024)
Figure 66. Egypt GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries GLP-1 Agonist Injection Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of GLP-1 Agonist Injection in 2023
Figure 72. Manufacturing Process Analysis of GLP-1 Agonist Injection
Figure 73. Industry Chain Structure of GLP-1 Agonist Injection
Figure 74. Channels of Distribution
Figure 75. Global GLP-1 Agonist Injection Sales Market Forecast by Region (2025-2030)
Figure 76. Global GLP-1 Agonist Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global GLP-1 Agonist Injection Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global GLP-1 Agonist Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global GLP-1 Agonist Injection Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global GLP-1 Agonist Injection Revenue Market Share Forecast by Application (2025-2030)
